Economic Evaluation of Dapagliflozin as Add-On to Metformin in T2DM in the Israeli Health Care Setting

被引：1

|

作者：

Moshel, Shai

Vexberg, Michal Hirsch

Shavit, Oren

Toledano, Yoel

机构：

来源：

DIABETES | 2018年 / 67卷

关键词：

D O I：

10.2337/db18-1297-P

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页数：2

相关论文

共 50 条

[31] Empaglifl ozin (EMPA) Compared with Glimepiride (GLIM) as Add-On to Metformin (MET) for 4 Years in Patients with Type 2 Diabetes (T2DM)
Ridderstrale, Martin
Robert, Knut
Toorawa, Andersen
Woerle, Hans J.
Salsali, Afshin
DIABETES, 2016, 65 : A47 - A48
[32] Patient Characteristics Associated with Add-On Medication Treatment for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy
Qiu, Ying
Fu, Alex Z.
Radican, Larry
DIABETES, 2010, 59 : A604 - A604
[33] Effectiveness and Safety of Hydroxychloroquine compared to Teneligliptin in uncontrolled T2DM patients as add-on Therapy
Kumar, Amit
Prakash, Akhouri Sukrit
JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2019, 34 (01): : 87 - 91
[34] Efficacy and Safety of Naltrexone/Bupropion as Add-On to Incretin Agents in Patients with Obesity and T2DM
Wharton, Sean
Yin, Peter
Camacho, Fernando
Burrows, Melonie
Blavignac, Jessica
Barakat, Maxime
DIABETES, 2020, 69
[35] Empagliflozin as Add-on to Linagliptin and Metformin in Patients with Type 2 Diabetes (T2DM): Subgroup Analysis by Region in a 24-Week Randomized Trial
Wanner, Christoph
Naderali, Ebrahim
Maldonaldo, Mario
Del Parigi, Angelo
Toorawa, Robert
Lee, Christopher
DIABETES, 2016, 65 : A288 - A289
[36] COST OF REACHING DEFINED HBA1C TARGET USING CANAGLIFLOZIN COMPARED TO DAPAGLIFLOZIN AS ADD-ON TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN THE UNITED ARAB EMIRATES (UAE)
Schubert, A.
Nielsen, A. T.
El Khoury, A.
Kamal, A.
Taieb, V
VALUE IN HEALTH, 2015, 18 (07) : A608 - A608
[37] Dapagliflozin plus Saxagliptin Add-On vs. Glimepiride Add-On to Metformin in Patients with Poorly Controlled Type 2 Diabetes
Frias, Juan P.
Gonzalez-Galvez, Guillermo
Johnsson, Eva K.
Maaske, Jill
Peters, Anne
DIABETES, 2018, 67
[38] DIABETES Dapagliflozin-redefining treatment of T2DM?
Chao, Edward C.
NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (12) : 696 - 697
[39] Dapagliflozin as an add-on to metformin lowers hyperglycaemia in type 2 diabetes patients inadequately controlled with metformin alone
Bailey, C. J.
Gross, J. L.
Bastone, L.
Bastien, A.
List, J. F.
DIABETOLOGIA, 2009, 52 : S76 - S76
[40] Insulin plus metformin for T2DM—are there benefits?
Clifford J. Bailey
Nature Reviews Endocrinology, 2012, 8 : 449 - 450

← 1 2 3 4 5 →